AI assistant
Sending…
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2016
Feb 1, 2016
31049_dirs_2016-02-01_0fbaa114-ce6b-46be-99f0-d0100a40405f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2016-01-28
Reporting Person: Frost Ronald (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-28 | Non-qualified stock options (right to buy) | $16.05 | A | 20000 | Acquired | 2023-01-28 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, No Par Value | 15953 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $13.75 | 2018-08-11 | Common Stock (15000) | 15000 | Direct |
| Non-qualified stock options (right to buy) | $13.14 | 2020-07-31 | Common Stock (10000) | 10000 | Direct |
| Non-qualified stock options (right to buy) | $12.06 | 2021-10-04 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $17.27 | 2022-02-13 | Common Stock (20000) | 20000 | Direct |
Footnotes
F1: Represents plan holdings as of 01/25/2016.
F2: Become exercisable in equal annual installments of 20% commencing 08/11/2012.
F3: Become exercisable in equal annual installments of 20% commencing 07/31/2014.
F4: Become exercisable in equal annual installments of 20% commencing 10/04/2015.
F5: Become exercisable in equal annual installments of 20% commencing 02/13/2016.
F6: Become exercisable in equal annual installments of 20% commencing 01/28/2017.
More from MERIT MEDICAL SYSTEMS INC
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Share Issue/Capital Change
2026
May 15
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 13
M&A Activity
2026
Apr 1
Annual Report
2026
Mar 31